Key facts
- This page summarizes Wayne Burris's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jun 2024, 17:06.
Wayne Burris - 31 May 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Director
- Issuer ticker
- AXDX
- Reported as of
- 31 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2024, 17:06:09 UTC
- Prior SEC filing
- 21 May 2024
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Patience, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Wayne Burris filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 03 Jun 2024.
Change
- Previous filing in this sequence was filed on 21 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +839
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 1,678
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -839
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 2,517
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 839
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
Footnote F2
On May 31, 2022, the reporting person was granted a total of 4,195 RSUs, which vest in five equal annual installments beginning on May 31, 2023.
SEC remarks
On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported after the effective date of the Reverse Stock Split, including the amounts reported herein (and to be reported in subsequent reports), have been adjusted to reflect the Reverse Stock Split.